A detailed history of True Private Wealth Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, True Private Wealth Advisors holds 9,338 shares of BMY stock, worth $539,362. This represents 0.06% of its overall portfolio holdings.

Number of Shares
9,338
Previous 13,407 30.35%
Holding current value
$539,362
Previous $556,000 13.13%
% of portfolio
0.06%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $161,376 - $210,570
-4,069 Reduced 30.35%
9,338 $483,000
Q2 2024

Jul 16, 2024

SELL
$40.25 - $52.99 $40,089 - $52,778
-996 Reduced 6.92%
13,407 $556,000
Q1 2024

Apr 25, 2024

BUY
$47.98 - $54.4 $30,947 - $35,088
645 Added 4.69%
14,403 $781,000
Q4 2023

Jan 30, 2024

SELL
$48.48 - $57.85 $2.33 Million - $2.78 Million
-48,125 Reduced 77.77%
13,758 $705,000
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $385,605 - $431,166
6,661 Added 12.06%
61,883 $3.59 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $74,222 - $82,412
1,165 Added 2.16%
55,222 $3.53 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $30,029 - $34,060
-457 Reduced 0.84%
54,057 $3.75 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $53,551 - $63,412
782 Added 1.46%
54,514 $3.92 Million
Q3 2022

Nov 04, 2022

BUY
$0.13 - $76.84 $379 - $224,372
2,920 Added 5.75%
53,732 $3.82 Million
Q2 2022

Jul 28, 2022

BUY
$72.62 - $79.98 $96,439 - $106,213
1,328 Added 2.68%
50,812 $3.91 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $2.46 Million - $2.94 Million
39,940 Added 418.48%
49,484 $3.78 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $28,584 - $33,323
-533 Reduced 5.29%
9,544 $595,000
Q3 2021

Nov 05, 2021

SELL
$59.17 - $69.31 $35,265 - $41,308
-596 Reduced 5.58%
10,077 $601,000
Q2 2021

Aug 10, 2021

BUY
$61.91 - $67.42 $85,126 - $92,702
1,375 Added 14.79%
10,673 $713,000
Q1 2021

May 12, 2021

SELL
$59.34 - $66.74 $282,636 - $317,882
-4,763 Reduced 33.87%
9,298 $592,000
Q4 2020

Jan 11, 2021

SELL
$57.74 - $65.43 $10,450 - $11,842
-181 Reduced 1.27%
14,061 $879,000
Q3 2020

Oct 09, 2020

BUY
$57.43 - $63.64 $59,440 - $65,867
1,035 Added 7.84%
14,242 $858,000
Q2 2020

Jul 07, 2020

BUY
$54.82 - $64.09 $75,651 - $88,444
1,380 Added 11.67%
13,207 $776,000
Q1 2020

Apr 20, 2020

SELL
$46.4 - $67.43 $43,616 - $63,384
-940 Reduced 7.36%
11,827 $659,000
Q4 2019

Jan 27, 2020

BUY
$49.21 - $64.19 $332,954 - $434,309
6,766 Added 112.75%
12,767 $819,000
Q3 2019

Oct 09, 2019

BUY
$42.77 - $50.71 $62,273 - $73,833
1,456 Added 32.04%
6,001 $304,000
Q2 2019

Aug 01, 2019

BUY
$44.62 - $49.34 $202,797 - $224,250
4,545 New
4,545 $206,000
Q4 2018

Jan 14, 2019

SELL
$48.76 - $63.23 $192,553 - $249,695
-3,949 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$55.19 - $62.25 $217,945 - $245,825
3,949 New
3,949 $0
Q2 2018

Jul 13, 2018

SELL
$50.53 - $62.98 $283,675 - $353,569
-5,614 Closed
0 $0
Q1 2018

Apr 25, 2018

SELL
$59.92 - $68.98 $23,069 - $26,557
-385 Reduced 6.42%
5,614 $355,000
Q4 2017

Jan 19, 2018

BUY
$59.94 - $65.35 $20,919 - $22,807
349 Added 6.18%
5,999 $367,000
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $1,435 - $1,657
26 Added 0.46%
5,650 $360,000
Q2 2017

Aug 07, 2017

BUY
N/A
5,624
5,624 $313,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.